01Cellebrite DI reported Q3 2026 EPS of $0.17, beating consensus estimates of $0.15 by $0.02 per share.
02Revenue reached $149.0M, exceeding the estimate of $145.8M in the third quarter.
03The stock trades at $12.52 with a market capitalization of $4.7 billion as of the earnings report.
04Cellebrite has beaten earnings estimates in three of the last four quarters, with Q1 showing a 33.3% surprise.
05Earnings surprises of this magnitude typically trigger analyst estimate revisions and can influence institutional positioning.
Earnings Results
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings results on November 12, 2026 that exceeded analyst expectations.
The Technology company reported earnings per share of $0.17, beating the consensus estimate of $0.15 by $0.02 per share. Revenue came in at $149.0M, beating the estimate of $145.8M.
Company Overview
Cellebrite DI's stock moved following the earnings release. The stock currently trades at $12.52 with a market capitalization of $4.7B.
Cellebrite DI's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 13% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Cellebrite DI should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.